Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$1.54 - $2.09 $5,154 - $6,995
-3,347 Reduced 15.93%
17,669 $33,000
Q4 2023

Feb 07, 2024

SELL
$1.47 - $2.22 $4,061 - $6,133
-2,763 Reduced 11.62%
21,016 $40,000
Q3 2023

Nov 02, 2023

BUY
$2.18 - $5.52 $7,913 - $20,037
3,630 Added 18.02%
23,779 $52,000
Q2 2023

Aug 07, 2023

BUY
$3.16 - $4.96 $13,872 - $21,774
4,390 Added 27.86%
20,149 $86,000
Q1 2023

May 09, 2023

BUY
$3.6 - $5.88 $6,825 - $11,148
1,896 Added 13.68%
15,759 $60,000
Q4 2022

Feb 09, 2023

BUY
$5.03 - $8.58 $9,768 - $16,662
1,942 Added 16.29%
13,863 $80,000
Q3 2022

Nov 09, 2022

BUY
$7.7 - $13.31 $91,791 - $158,668
11,921 New
11,921 $92,000

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $135M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.